Malaria assistance bi-hydrogen arteannuin suppository

Abstract

The invention aims at providing an anti-malarial dihydroartemisinin suppository, which is a rectum or anus dosage regimen, and has the advantages of low recurrence rate, low toxicity, safety, short treatment period, quick results, low cost and speeding up healing process after being used by malaria-patients, thus removing the diseases. The anti-malarial dihydroartemisinin suppository is prepared by adding dihydroartemisinin with suppository base, and the content of the dihydroartemisinin in each grain of the suppository is 10-100mg.

Description

technical field [0001] The invention relates to an antimalarial drug, in particular to an antimalarial dihydroartemisinin suppository and the technical field of production thereof. Background technique [0002] According to statistics, about 300 million people are infected with malaria every year, most of them in Africa, and 1 million of them die, mostly children. Dr Attaran, an associate research fellow at the Royal Institute of International Affairs in London, said children who did not die were often left with physical or mental disabilities. Artemisinin is extracted from Artemisia annua, a traditional Chinese medicine with a history of two thousand years. Studies have proved that the drug has 97% efficacy in treating malaria. Dihydroartemisinin is a derivative of Artemisia annua, which is characterized by high efficiency and quick-acting , Short-acting antimalarials. Oral drugs based on dihydroartemisinin have been widely used clinically and put into use in countries wh...

AI Technical Summary

Problems solved by technology

Oral drugs based on dihydroartemisinin have been widely used clinically and put into use in countries where malaria is rampant. However, these drugs are not effective in treating children and coma and vomiting patients, and the dosage is not accurate enough, so that complex High burning rate and high toxic side effects